A 72-year-old Caucasian male presented with a four month history of an asymptomatic, violaceous, ulcerated tumor over the scalp of 3 cm diameter surrounded by multifocal violaceous nodules [ Figure 1 ]. He reported local trauma 1 month prior to appearance of the lesion. There was no lymphadenopathy or hepatosplenomegaly. Histopathologic examination showed a vascular tumoral lesion occupying the entire dermis, with a jagged irregular branching angiomatous pattern with vascular clefts between the collagen fibers filled with erythrocytes and lymphocytes around vessels [ Figure 2a ]. The endothelial cells were polygonal with hyperchromatic nuclei and rare atypical mitoses. The immunostaining was positive for CD31, CD34 and FVIII-related antigen [ Figure 2b ].
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WHAT IS THE DIAGNOSIS?
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Scalp Tumor
Leonor Neto Lopes, Luís Soares-Almeida, Paulo Filipe Cutaneous angiosarcoma is a rare, malignant tumor of vascular endothelial cells. [1, 2] It usually affects the face and scalp region, most often in elderly patients. [1, 2] Men are more frequently affected than women in a ratio of 3:1. [2] The clinical presentation of angiosarcoma is quite variable. [2] It has three clinical settings: Angiosarcoma in the elderly, post-radiation, or associated with chronic lymphedema. [3, 4] Angiosarcoma accounts for approximately 10% of soft-tissue sarcomas of the head and neck. [2, 5] It is histopathologically characterized by irregular vascular channels dissecting between collagen bundles lined by hyperchromatic atypical endothelium and chronic inflammation. [3] Vascular and lymphatic immunohistochemical markers are essential to establish the diagnosis -CD31, CD34, factor-VIII and podoplanin are positive. [3, 5, 6] One of the main differential diagnoses is Kaposi sarcoma, in which spindled cells are CD34 and variably CD31 positive, but anti-human herpes-virus-8 antibody is always positive. [3] Angiosarcoma treatment includes surgery, wide-field post-operative radiotherapy and/or palliative chemotherapy. [5] The local-regional recurrence is high and the prognosis very poor (5-year survival rate of approximately 10%). [2] This tumor can metastasize by lymphatic or hematogenous routes to the lung, lymph nodes and bone. [2, 5] The most important determinant factors of outcome are tumor diameter, depth of invasion, margin status, recurrence and metastasis. [5, 7] 
